Matrix metalloproteinase-1 promotes muscle cell migration and differentiation

American Journal of Pathology

Volumn 174, Issue 2, 2009, Pages 541-549

  Wang, William ^a,b   Pan, Haiying ^b   Murray, Kiley ^b   Jefferson, Bahiyyah S ^b   Li, Yong ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL TRANSPLANTATION; CHEMOTAXIS; CONTROLLED STUDY; MOUSE; MUSCLE CELL; MUSCLE FUNCTION; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

EID: 59649100885     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080509     Document Type: Article

References (60)

1. Garrett Jr WE: Muscle strain injuries: clinical and basic aspects. Med Sci Sports Exerc 1990, 22:436-443
2. Li Y, Cummins J, Huard J: Muscle injury and repair. Curr Opin Orthop 2001, 12:409-415
3. Lehto MU, Jarvinen MJ: Muscle injuries, their healing process and treatment. Ann Chir Gynaecol 1991, 80:102-108
4. Chan YS, Li Y, Foster W, Horaguchi T, Somogyi G, Fu FH, Huard J: Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol 2003, 95:771-780
5. Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J: The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 2001, 29:394-402
6. Li Y, Huard J: Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 2002, 161:895-907
7. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J, Huard J: Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 2004, 164:1007-1019
8. Sato K, Li Y, Foster W, Fukushima K, Badlani N, Adachi N, Usas A, Fu FH, Huard J: Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve 2003, 28:365-372
9. Hoffman EP, Brown Jr RH, Kunkel LM: Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928
10. Partridge TA: Invited review: myoblast transfer: a possible therapy for inherited myopathies? Muscle Nerve 1991, 14:197-212
11. Iimuro Y, Nishio T, Morimoto T, Nitta T, Stefanovic B, Choi SK, Brenner DA, Yamaoka Y: Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 2003, 124:445-458
12. Karpati G, Holland P, Worton RG: Myoblast transfer in DMD: problems in the interpretation of efficiency. Muscle Nerve 1992, 15:1209-1210
13. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM: Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989, 337:176-179
14. Huard J, Bouchard JP, Roy R, Labrecque C, Dansereau G, Lemieux B, Tremblay JP: Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy. Clin Sci (Lond) 1991, 81:287-288
15. Skuk D: Myoblast transplantation for inherited myopathies: a clinical approach. Expert Opin Biol Ther 2004, 4:1871-1885
16. Caron NJ, Asselin I, Morel G, Tremblay JP: Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant 1999, 8:465-476
17. Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL: Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993, 2:99-112
18. Sato H, Okada Y, Seiki M: Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb Haemost 1997, 78:497-500
19. Werb Z, Chin JR: Extracellular matrix remodeling during morphogenesis. Ann NY Acad Sci 1998, 857:110-118
20. Bedair H, Liu TT, Kaar JL, Badlani S, Russell AJ, Li Y, Huard J: Matrix metalloproteinase-1 therapy improves muscle healing. J Appl Physiol 2007, 102:2338-2345
21. Huard J, Li Y, Fu FH: Muscle injuries and repair: current trends in research. J Bone Joint Surg Am 2002, 84A:822-832
22. Brinckerhoff CE, Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002, 3:207-214
23. Sakaida I, Hironaka K, Kimura T, Terai S, Yamasaki T, Okita K: Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell. Life Sci 2004, 74:2251-2263
24. Roach DM, Fitridge RA, Laws PE, Millard SH, Varelias A, Cowled PA: Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg 2002, 23:260-269
25. Vincenti MP, Brinckerhoff CE: Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 2002, 4:157-164
26. McCawley LJ, Matrisian LM: Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001, 13:534-540
27. Pardo A, Selman M: MMP-1: the elder of the family. Int J Biochem Cell Biol 2005, 37:283-288
28. Kaar JL, Li Y, Blair HC, Asche G, Koepsel RR, Huard J, Russell AJ: Matrix metalloproteinase-1 treatment of muscle fibrosis. Acta Biomater 2008, 4:1411-1420
29. Brand-Saberi B, Gamel AJ, Krenn V, Muller TS, Wilting J, Christ B: N-cadherin is involved in myoblast migration and muscle differentiation in the avian limb bud. Dev Biol 1996, 178:160-173
30. Woodfield RJ, Hodgkin MN, Akhtar N, Morse MA, Fuller KJ, Saqib K, Thompson NT, Wakelam MJ: The p85 subunit of phosphoinositide 3-kinase is associated with beta-catenin in the cadherin-based adhesion complex. Biochem J 2001, 360:335-344
31. Takino T, Watanabe Y, Matsui M, Miyamori H, Kudo T, Seiki M, Sato H: Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration. Exp Cell Res 2006, 312:1381-1389
32. Ohtake Y, Tojo H, Seiki M: Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle. J Cell Sci 2006, 119:3822-3832
33. Mendes O, Kim HT, Lungu G, Stoica G: MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin Exp Metastasis 2007, 24:341-351
34. Gong YL, Xu GM, Huang WD, Chen LB: Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer. J Surg Oncol 2000, 73:95-99
35. Kim HJ, Park CI, Park BW, Lee HD, Jung WH: Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast. Yonsei Med J 2006, 47:333-342
36. Bischoff R: The Satellite Cell and Muscle Regeneration. Edited by Engel AG, Franzini-Armstrong C. New York, McGraw-Hill, 1994, pp 97-118
37. Lluri G, Jaworski DM: Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation. Muscle Nerve 2005, 32:492-499
38. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ: The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 1989, 244:1578-1580
39. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN: Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166:7556-7562
40. Crisco JJ, Jokl P, Heinen GT, Connell MD, Panjabi MM: A muscle contusion injury model. Biomechanics, physiology, and histology. Am J Sports Med 1994, 22:702-710
41. Foster W, Li Y, Usas A, Somogyi G, Huard J: Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthop Res 2003, 21:798-804
42. Velleman SG: The role of the extracellular matrix in skeletal muscle development. Poult Sci 1999, 78:778-784
43. Menetrey J, Kasemkijwattana C, Fu FH, Moreland MS, Huard J: Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model. Am J Sports Med 1999, 27:222-229
44. Li Y, Fu FH, Huard J. Cutting-edge muscle recovery: using anti fibrosis agents to improve healing. J Physician and Sports Medicine 2005, 33:44-50
45. El Fahime E, Torrente Y, Caron NJ, Bresolin MD, Tremblay JP: In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res 2000, 258:279-287
46. Lewis MP, Tippett HL, Sinanan AC, Morgan MJ, Hunt NP: Gelatinase-B (matrix metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures. J Muscle Res Cell Motil 2000, 21:223-233
47. Skuk D, Goulet M, Roy B, Chapdelaine P, Bouchard JP, Roy R, Dugre FJ, Sylvain M, Lachance JG, Deschenes L, Senay H, Tremblay JP: Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006, 65:371-386
48. Skuk D, Goulet M, Roy B, Piette V, Cote CH, Chapdelaine P, Hogrel JY, Paradis M, Bouchard JP, Sylvain M, Lachance JG, Tremblay JP: First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul Disord 2007, 17:38-46
49. Carmeli E, Moas M, Reznick AZ, Coleman R: Matrix metalloproteinases and skeletal muscle: a brief review. Muscle Nerve 2004, 29:191-197
50. Rivilis I, Milkiewicz M, Boyd P, Goldstein J, Brown MD, Egginton S, Hansen FM, Hudlicka O, Haas TL: Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis. Am J Physiol 2002, 283:H1430-H1438
51. Yamada M, Tatsumi R, Kikuiri T, Okamoto S, Nonoshita S, Mizunoya W, Ikeuchi Y, Shimokawa H, Sunagawa K, Allen RE: Matrix metalloproteinases are involved in mechanical stretch-induced activation of skeletal muscle satellite cells. Muscle Nerve 2006, 34:313-319
52. Bandow K, Ohnishi T, Tamura M, Semba I, Daikuhara Y: Hepatocyte growth factor/scatter factor stimulates migration of muscle precursors in developing mouse tongue. J Cell Physiol 2004, 201:236-243
53. Kleiner DE, Stetler-Stevenson WG: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999, 43:S42-S51
54. Chin JR, Werb Z: Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development 1997, 124:1519-1530
55. Brauer PR: MMPs - role in cardiovascular development and disease. Front Biosci 2006, 11:447-478
56. Seiki M: Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 2003, 194:1-11
57. Allen DL, Teitelbaum DH, Kurachi K: Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro. Am J Physiol 2003, 284:C805-C815
58. Langlois S, Nyalendo C, Di Tomasso G, Labrecque L, Roghi C, Murphy G, Gingras D, Beliveau R: Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation. Mol Cancer Res 2007, 5:569-583
59. Lluri G, Langlois GD, Soloway PD, Jaworski DM: Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro. Exp Cell Res 2008, 314:11-24
60. Zimowska M, Brzoska E, Swierczynska M, Streminska W, Moraczewski J: Distinct patterns of MMP-9 and MMP-2 activity in slow and fast twitch skeletal muscle regeneration in vivo. Int J Dev Biol 2008, 52:307-314